PMS-DESONIDE DIN 02516349
Health Canada record
| Active ingredient(s) | DESONIDE 0.05 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D07AB08 DESONIDE |
| Original market date | |
| Current status date | 01-Jun-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DESONIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02229315 | PDP-DESONIDE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Cream | DESONIDE 0.05 % | Marketed |
| 02229323 | PDP-DESONIDE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Ointment | DESONIDE 0.05 % | Marketed |
| 02516357 | PMS-DESONIDE | PHARMASCIENCE INC | Ointment | DESONIDE 0.05 % | Approved |
| 02154862 | TRIDESILON 0.05% DESONIDE CREAM | PERRIGO INTERNATIONAL | Cream | DESONIDE 0.05 % | Cancelled Post Market |
| 02154870 | TRIDESILON 0.05% DESONIDE OINTMENT | PERRIGO INTERNATIONAL | Ointment | DESONIDE 0.05 % | Cancelled Post Market |
| 02348489 | VERDESO | GLAXOSMITHKLINE INC | Aerosol (Foam) | DESONIDE 0.05 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25963 | 2021-06-01 | New Drug Submission (NDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
International API supply for DESONIDE
32 active FDA Drug Master Files.
Request a quote for PMS-DESONIDE